Bruce Motyka
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Repeat ABO-B-incompatible living-donor kidney transplantation.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 09, 2025
Multiplex bead immunoassay in ABO-A2-incompatible kidney transplantation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: February 06, 2025
ABO-A antibody induction in mice is T cell-dependent, estrogen-independent, and modulated by CD22.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: December 18, 2024
Sex, T Cells, and the Microbiome in Natural ABO Antibody Production in Mice.
Journal: Transplantation
Published: October 23, 2023
Extending the in vivo persistence of synthetic glycoconjugates using a serum-protein binder.
Journal: RSC chemical biology
Published: May 19, 2022
ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2.
Journal: Virulence
Published: December 30, 2021
Alterations in the immune phenotype of thymectomized children and the development of atopic disorders after heart transplantation.
Journal: Pediatric transplantation
Published: May 31, 2021
CD71+ Erythroid Cells in Human Neonates Exhibit Immunosuppressive Properties and Compromise Immune Response Against Systemic Infection in Neonatal Mice.
Journal: Frontiers in immunology
Published: August 21, 2020
Characterization of ABH-subtype donor-specific antibodies in ABO-A-incompatible kidney transplantation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: July 16, 2020
A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B.
Journal: Human vaccines & immunotherapeutics
Published: November 06, 2019
A dendritic cell-targeted chimeric hepatitis B virus immunotherapeutic vaccine induces both cellular and humoral immune responses in vivo.
Journal: Human vaccines & immunotherapeutics
Published: November 06, 2019
Last Updated: 09/26/2026